학술논문
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
Document Type
Article
Author
VanderWalde, A.; Portnoy, D.C.; Bellasea, S.L.; Moon, J.; Wu, M.C.; Kendra, K.L.; Khushalani, N.I.; Eroglu, Z.; Campbell, K.M.; Scumpia, P.O.; Kuklinski, L.F.; Chmielowski, B.; Medina, E.; Gonzalez, C.R.; Baselga-Carretero, I.; Vega-Crespo, A.; Garcilazo, I.P.; Ribas, A.; Collichio, F.; Sosman, J.A.; Chandra, S.; Ikeguchi, A.; Victor, A.I.; Truong, T.-G.; Chen, Y.; Margolin, K.; Bane, C.; Dasanu, C.A.; Johnson, D.B.; Sharon, E.; Hu-Lieskovan, S.; Grossmann, K.F.; Patel, S.P.
Source
In: Nature Medicine . (Nature Medicine, September 2023, 29(9):2278-2285)
Subject
Language
English
ISSN
1546170X
10788956
10788956